# Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

> **NCT07091500** · NA · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 40 (estimated)

## Conditions studied

- Obesity
- Skeletal Muscle

## Interventions

- **BEHAVIORAL:** Exercise training
- **DRUG:** Semaglutide

## Key facts

- **NCT ID:** NCT07091500
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-11
- **Primary completion:** 2028-08-01
- **Final completion:** 2029-08-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091500, "Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07091500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*